Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Benefits of Focused Ultrasound Thalamotomy For Essential Tremor Persist For 3 Years

Publish date:: November 21, 2019

Key clinical point: Focused ultrasound thalamotomy provides benefit over 3 years in patients with medication-refractory essential tremor.

Major finding: At 3 years, the range of improvement in hand tremor from baseline was 38%-50%.

Study details: Long-term follow up of 75 patients in a randomized controlled trial of focused ultrasound thalamotomy for essential tremor.

Disclosures: InSightec, the maker of the focused ultrasound equipment used in the study, supported the study. Several of the investigators received research funding from InSightec.

Citation:

Halpern CH et al. Neurology. 2019 Nov 20 (Epub ahead of print).

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Neuromuscular Disorders

Gene-replacement therapy shows promise in X-linked myotubular myopathy,

Ataluren delays disease milestones in patients with nonsense mutation DMD,

Nusinersen provides continued benefits to presymptomatic children with SMA,

Huntington's disease biomarkers appear 24 years before clinical symptoms,

Dermatomyositis without dermatitis correlates with autoantibodies,